Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy.
Aourz N, Serruys AK, Chabwine JN, Balegamire PB, Afrikanova T, Edrada-Ebel R, Grey AI, Kamuhabwa AR, Walrave L, Esguerra CV, van Leuven F, de Witte PAM, Smolders I, Crawford AD.
Aourz N, et al. Among authors: kamuhabwa ar.
ACS Chem Neurosci. 2019 Apr 17;10(4):1992-2003. doi: 10.1021/acschemneuro.8b00281. Epub 2018 Nov 6.
ACS Chem Neurosci. 2019.
PMID: 30351911
Free article.